3Blumgart LH,Allison DJ. Resection mid embolization in the management of secondary hepatic tumors. World J Surg, 1982;6:32- 45.
4Ilyas M, Tomlinson IPM. Genetic pathways in colorectal cancer[J]. Flistopathology, 1996;28:389--399.
5Steeg PS, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low minor metastatic potential[J]. J Natl Cancer Inst, 1988;80:200--204.
6Cheah PY, Cae X, Eu KW, et al. NM23 - HI immunostaining in inversely associated with tumor staging but not overall survival or disease recurrence in colorectal carcinomas[J]. Br J Cancer, 1998;77(7) : 1164.
7Cohn KH, Ornstein DL, Wong F, et al. The significance of allelic deletions, and an - enploidy in colorectal carcinoma. Results of a 5 -year follow- up study[J]. Cancer, 1997 ;79(2) : 233.
8Bemey CR, Yang JL, Fisher RI, et al. Overexpression of nm23 protein assessed by color video image analysis in metastastic colorectal cancer: correlation with reduced patient survival [J]. World J Surg, 1998;22(5):484.
9Saleh M, Stacker SA, Wilks AF. Inhibition of growth of c6 glioma cell in vive by expression of antisence vascular endothelial growth factor sequence[J]. Cancer Res, 1996;.56:393.
10Nanashima A, Ito M, Sekine I, et al. Significance of angiogenic factors in liver metastasis tumor originating from colorectal cancers[J]. Dig Dis Sci, 1998;43(12):2634.
